The use of polymers and polymeric structures in the treatment, diagnosis, and monitoring of biological systems is continuing to increase in sophistication. Research exploring the use of nanoparticles for drug delivery applications has included the exploration and development of nanocolloids, liposomes, micelles, nanogels, polymer‐drug conjugates, and a variety of other polymeric nanoparticles that are composed of organic polymers with specific physical or chemical properties that make them relevant delivery vehicles. One of the current trends is the fabrication of tunable, mono‐dispersed, polymeric nanostructures to be used as nanoparticle drug delivery platforms. The PRINT technology used to fabricate monodisperse particles from a wide range of particle matrix materials including biocompatible poly(ethylene glycol) and bioabsorbable poly(d‐lactic acid) is described along with an abbreviated overview of other polymeric drug delivery platforms.
Nanoparticle Drug Delivery Platform
Log in via your institution
Log in to Taylor & Francis Online
Restore content access
Restore content access for purchases made as guestPDF download + Online access
- 48 hours access to article PDF & online version
- Article PDF can be downloaded
- Article PDF can be printed
Issue Purchase
- 30 days online access to complete issue
- Article PDFs can be downloaded
- Article PDFs can be printed
Related Research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.